Premium
Therapeutic molecular targets in human chondrosarcoma
Author(s) -
Jamil Nuor,
Howie Sarah,
Salter Donald M.
Publication year - 2010
Publication title -
international journal of experimental pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.671
H-Index - 72
eISSN - 1365-2613
pISSN - 0959-9673
DOI - 10.1111/j.1365-2613.2010.00749.x
Subject(s) - chondrosarcoma , radiation therapy , chondrocyte , medicine , chemotherapy , cartilage , cancer research , apoptosis , resection , surgical resection , oncology , pathology , surgery , biology , anatomy , biochemistry
Summary Chondrosarcomas are malignant cartilage tumours. They are poorly responsive to chemotherapy and radiotherapy. Treatment is usually limited to surgical resection; however, survival of patients with high‐grade chondrosarcoma is poor, even with wide surgical resection. Induction of apoptosis in chondrosarcoma cells, either directly or by enhancement of the response to chemotherapeutic drugs and radiation, may be a route by which outcome can be improved. In this article, we review potential molecular targets that regulate chondrocyte apoptosis and discuss the experimental evidence for their utility.